Vanta Bioscience Ltd.

53.86 ▼0%

22 November 2023, 04:01:00 PM

Company Profile

Sector Miscellaneous Compare with Sector peers
Industry Miscellaneous Compare with Industry peers
Website http://www.vantabio.com
Market Cap 34.00 Cr.
Enterprise Value(EV) 58.60 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -10.27 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-03
Industry PE 69.77 Trailing Twelve Months Ending 2023-03
Book Value / Share 27.75 Trailing Twelve Months Ending 2023-03
Price to Book Value 1.94 Calculated using Price: 53.86
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.63 Cr. 6,312,000 Shares
FaceValue 10
About Vanta Bioscience Ltd.
The company is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries. In addition they also provide risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product. VBS also provides expert services for determination of health based exposure limits (e.g. permitted daily exposure (PDE) or allowable daily exposure (ADE) including occupational exposure limits (OEL) for pharmaceutical manufacturers. Their services include toxicology, batch release tests, biocompatibility studies, chemical safety, and diet formulation.

Vanta Bioscience Ltd. Delivery

Delivered Qty
Traded Qty

Vanta Bioscience Ltd. Performance

1 Day
1 Week
-3.82%
1 Month
+28.85%
3 Month
-8.40%
6 Month
+1.89%
1 Year
-27.07%
2 Year
-48.70%
5 Year
-42.58%
10 Year

Vanta Bioscience Ltd. Fundamental Ratios

5 years 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 3.14 4.43 1.89 0.56 -50.31
Return on Capital Employed (%) 7.87 8.62 5.42 4.00 -6.10
Return on Assets (%) 1.78 2.31 0.76 0.18 -12.57

Vanta Bioscience Ltd. Balance Sheet

Particulars 6 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 22 23 24 24 18 17
Non Curr. Liab. 13 14 29 38 48 47
Curr. Liab. 3 10 15 14 18 18
Minority Int. 1 1 2 5 1 2
Equity & Liab. 39 49 70 81 85 85
Non Curr. Assets 22 29 50 67 69 69
Curr. Assets 17 20 20 15 15 15
Misc. Exp. not W/O
Total Assets 39 49 70 81 85 85

Vanta Bioscience Ltd. Profit and Loss

Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Net Sales 12 14 10 10 6
Other Income 0 0 0 0 1
Total Income 12 14 10 10 7
Total Expenditure -9 -9 -6 -6 -9
PBIDT 4 4 4 4 -2
Interest -2 -2 -2 -2 -6
Depreciation -1 -1 -1 -1 -3
Taxation 0 0 0 0 0
Exceptional Items
PAT 1 1 0 0 -10
Minority Interest 0 0 4
Share Associate
Other Related Items
Consolidated Net Profit 1 1 0 0 -6
Adjusted EPS 1 2 1 0 -10

Vanta Bioscience Ltd. Cash Flow

Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -1 2 7 5 -1
Cash Fr. Inv. -6 -7 -22 -17 -6
Cash Fr. Finan. 10 2 18 9 6
Net Change 3 -3 2 -2 0
Cash & Cash Eqvt 3 0 3 0 0

Vanta Bioscience Ltd. Shareholding Pattern

9 Qtrs 2019-09 (%) 2020-03 (%) 2020-09 (%) 2021-03 (%) 2021-09 (%) 2022-03 (%) 2022-09 (%) 2023-03 (%) 2023-09 (%)
Promoter 69.93 69.93 69.93 69.11 69.00 69.00 69.36 69.36 69.36
Public 30.07 30.07 30.07 30.89 31.00 31.00 30.64 30.64 30.64
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Vanta Bioscience Ltd. Announcements

Tue, 14 Nov 2023
Change In Designation Of Dr. Vyasmurti Madhavrao Shingatgeri (DIN 07728757) From Whole Time Director To Non-Executive Director W.E.F 14.11.2023.
Change in Designation of Dr. Vyasmurti Madhavrao Shingatgeri from WTD to Non Executive Director w.e.f 14.11.2023
Tue, 14 Nov 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On 14.11.2023
Outcome of Board Meeting held on 14.11.2023
Wed, 08 Nov 2023
Board Meeting Intimation for Approval Of Unaudited Financial Statements For The Period Ended 30.09.2023
Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 inter alia to consider and approve the un-audited financial results of the Company for the half year ended 30.09.2023 and to take note of the Statutory Auditors limited review reports thereon.

Vanta Bioscience Ltd. Technical Scans

Wed, 22 Nov 2023
Opening at Low Opening at Low
Closing Above Previous High Closing Above Previous High
Close Below Last Week Low Close Below Last Week Low
Close Above Last Month High Close Above Last Month High
High Increase in 1 Month High Increase in 1 Month

Vanta Bioscience Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Latent View Analytics Ltd. 9,868.98 480.00 +2.7%
Updater Services Ltd. 1,782.63 267.35 -0.2%
Quint Digital Ltd. 702.05 148.60 +0.1%
Vaarad Ventures Ltd. 402.34 16.10 +1.3%
PE Analytics Ltd. 274.63 262.00 -1.5%
Gretex Corporate Services Ltd. 221.10 192.00 -3.0%
Spectrum Talent Management Ltd. 217.08 94.00 -0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Latent View Analytics Ltd. Consolidated 2023-09 64.27 480.00 +2.7%
Updater Services Ltd. Consolidated 2023-03 49.81 267.35 -0.2%
Quint Digital Ltd. Consolidated 2023-09 0.00 148.60 +0.1%
Vaarad Ventures Ltd. Consolidated 2023-09 0.00 16.10 +1.3%
PE Analytics Ltd. Standalone 2023-03 30.62 262.00 -1.5%
Gretex Corporate Services Ltd. Standalone 2023-03 39.07 192.00 -3.0%
Spectrum Talent Management Ltd. Standalone 2023-03 8.03 94.00 -0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Latent View Analytics Ltd. Consolidated 2023-09 7.71 480.00 +2.7%
Updater Services Ltd. Consolidated 2023-03 1.26 267.35 -0.2%
Quint Digital Ltd. Consolidated 2023-09 3.43 148.60 +0.1%
Vaarad Ventures Ltd. Consolidated 2023-09 17.77 16.10 +1.3%
PE Analytics Ltd. Standalone 2023-03 4.28 262.00 -1.5%
Gretex Corporate Services Ltd. Standalone 2023-03 4.95 192.00 -3.0%
Spectrum Talent Management Ltd. Standalone 2023-03 1.37 94.00 -0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Latent View Analytics Ltd. Consolidated 2023-03 0.00 480.00 +2.7%
Updater Services Ltd. Consolidated 2023-03 0.47 267.35 -0.2%
Quint Digital Ltd. Consolidated 2023-03 0.35 148.60 +0.1%
Vaarad Ventures Ltd. Consolidated 2023-03 0.15 16.10 +1.3%
PE Analytics Ltd. Standalone 2023-03 0.00 262.00 -1.5%
Gretex Corporate Services Ltd. Standalone 2023-03 0.00 192.00 -3.0%
Spectrum Talent Management Ltd. Standalone 2023-03 0.07 94.00 -0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Latent View Analytics Ltd. Consolidated 2023-03 13.97 480.00 +2.7%
Updater Services Ltd. Consolidated 2023-03 9.72 267.35 -0.2%
Quint Digital Ltd. Consolidated 2023-03 -21.87 148.60 +0.1%
Vaarad Ventures Ltd. Consolidated 2023-03 -0.99 16.10 +1.3%
PE Analytics Ltd. Standalone 2023-03 17.56 262.00 -1.5%
Gretex Corporate Services Ltd. Standalone 2023-03 29.13 192.00 -3.0%
Spectrum Talent Management Ltd. Standalone 2023-03 70.45 94.00 -0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Latent View Analytics Ltd. Consolidated 2023-03 13.97 480.00 +2.7%
Updater Services Ltd. Consolidated 2023-03 9.72 267.35 -0.2%
Quint Digital Ltd. Consolidated 2023-03 -21.87 148.60 +0.1%
Vaarad Ventures Ltd. Consolidated 2023-03 -0.99 16.10 +1.3%
PE Analytics Ltd. Standalone 2023-03 17.56 262.00 -1.5%
Gretex Corporate Services Ltd. Standalone 2023-03 29.13 192.00 -3.0%
Spectrum Talent Management Ltd. Standalone 2023-03 70.45 94.00 -0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Latent View Analytics Ltd. Consolidated 2023-03 538.76 480.00 +2.7%
Updater Services Ltd. Consolidated 2023-03 2,098.89 267.35 -0.2%
Quint Digital Ltd. Consolidated 2023-03 74.48 148.60 +0.1%
Vaarad Ventures Ltd. Consolidated 2023-03 16.10 +1.3%
PE Analytics Ltd. Standalone 2023-03 29.05 262.00 -1.5%
Gretex Corporate Services Ltd. Standalone 2023-03 12.63 192.00 -3.0%
Spectrum Talent Management Ltd. Standalone 2023-03 768.04 94.00 -0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Latent View Analytics Ltd. Consolidated 2023-03 155.43 480.00 +2.7%
Updater Services Ltd. Consolidated 2023-03 34.61 267.35 -0.2%
Quint Digital Ltd. Consolidated 2023-03 -28.18 148.60 +0.1%
Vaarad Ventures Ltd. Consolidated 2023-03 -0.23 16.10 +1.3%
PE Analytics Ltd. Standalone 2023-03 10.61 262.00 -1.5%
Gretex Corporate Services Ltd. Standalone 2023-03 6.52 192.00 -3.0%
Spectrum Talent Management Ltd. Standalone 2023-03 27.81 94.00 -0.4%

Vanta Bioscience Ltd. FAQ's

What is Vanta Bioscience share price?

Can I buy Vanta Bioscience shares now?

What is the Market Cap of Vanta Bioscience?

What are the key metrics to analyse Vanta Bioscience?

What is the 52 Week High and Low of Vanta Bioscience?